A fetus, although semi-allogeneic, is usually accepted by the maternal immune system. However, complications, including alloresponsive mechanisms, are thought to be potentially detrimental for a successful pregnancy. Therefore, we compared allogeneic T cell responses of nonpregnant women with the response of healthy pregnant women and pregnant women who have various gestation-associated diseases. Peripheral blood mononuclear cells (PBMCs) of all three groups were stimulated with PBMCs from unrelated volunteers. Pregnant women had significantly reduced stimulation indices (SIs) compared with nonpregnant women. Exposing PBMCs from pregnant women to PBMCs of their own fetus led to a further significant decrease of SIs. Among the two groups of pregnant individuals, SIs of women with prolonged preterm rupture of fetal membranes (PPROM) were significantly higher when the maternal PBMCs were stimulated with PBMCs of their own fetus. This phenomenon could not be observed after stimulation with PBMCs from unrelated volunteers. In addition, an increased humoral immune response was assessed for women with PPROM in comparison with women with uncontrollable preterm labor. Our results revealed a strongly reduced allogeneic T cell response of PBMCs from pregnant women that was further down-regulated when PBMCs from their own fetus were used as stimulators. By contrast, data from women with PPROM suggest an increased maternal T cell response specifically toward the fetal HLA antigens. During pregnancy the maternal immune system is confronted with paternal allo-antigens expressed by the fetal tissues. Therefore, maternal immune rejection processes toward fetal HLA antigens may represent a major cause of complications, such as uncontrollable preterm labor (PL), prolonged preterm rupture of fetal membranes (PPROM), pregnancyinduced hypertensive diseases [preeclampsia; hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome] or intrauterine growth restriction (IUGR). Several local mechanisms that act at the maternal-fetal interface to protect the fetus from maternal immune attack are known (1). In addition, mechanisms that induce peripheral immune tolerance to the fetus seem to be of equal if not of greater importance for successful course of pregnancy.One such mechanism is most possibly the induction of CD25ϩCD4ϩ T regulatory cells, a specialized T cell population that was shown not only to suppress autoaggressive immune responses (2) but also to prevent graft rejection as a result of induction of transplantation tolerance (3). Pregnancyinduced expansion of these regulatory T cells occurs in both mice (4) and humans (5). These cells were able to suppress the allogeneic T cell response directed against the fetus (4). Recently, it was reported that normal human pregnancy also is Received November 17, 2004; accepted February 11, 2005